Loading...
Hsp70 release from peripheral blood mononuclear cells
Hunter-Lavin, Claire Davies, Emma L. Bacelar, Maria M. F. V. G. Marshall, Michael J. Andrew, Sarah M. Williams, John H. H.
Hunter-Lavin, Claire
Davies, Emma L.
Bacelar, Maria M. F. V. G.
Marshall, Michael J.
Andrew, Sarah M.
Williams, John H. H.
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2004-11-12
Submitted Date
Collections
Other Titles
Abstract
There are an increasing number of studies reporting the presence of Hsps in human serum. We have investigated the release of Hsp70 into blood and culture medium from peripheral blood mononuclear cells (PBMCs), and whether this release is due to cell damage or active secretion from the cells. Intact Hsp70 was released from cells within whole blood and from purified PBMCs under normal culture conditions. Hsp70 release was rapid (0.1 ng/106 cells/h) over the first 2 h of culture and continued at a reduced rate up to 24 h (<0.025 ng/106 cells/h). Using viable cell counts and lactate dehydrogenase release we were able to confirm that the release of Hsp70 was not due to cellular damage. Hsp70 release was inhibited by monensin, methyl-β-cyclodextrin, and methylamine, but not by brefeldin A. These data suggest that Hsp70 is released from cells via a non-classical pathway, possibly involving lysosomal lipid rafts.
Citation
Biochemical and Biophysical Research Communications, 324(2), 2004, pp. 511-517
Publisher
Elsevier
Journal
Biochemical and Biophysical Research Communications
Research Unit
DOI
10.1016/j.bbrc.2004.09.075
PubMed ID
PubMed Central ID
Type
Article
Language
en
Description
This article is not available through ChesterRep.
Series/Report no.
ISSN
0006-291X
1090-2104
1090-2104
EISSN
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
This article was submitted to the RAE2008 for the University of Chester - Allied Health Professions and Studies.